Why is SK Biopharmaceuticals stock surging today?

Why is SK Biopharmaceuticals stock surging today?

Why is SK Biopharmaceuticals stock surging today?
Vishal Garg isn’t backing down from the company he founded. Processing Content The ex-CEO of Better Home & Finance is formally soliciting shareholder support for his comeback bid, after the lender cried foul over his initial attempts to rally shareholders. The company sued Garg Tuesday in federal court for alleged violations of securities laws, as…
Munis were mixed on Friday, as U.S. Treasuries cheapened and equities ended mixed. Processing Content Tax-exempt issuance for the week of Aug. 17 is projected to be nearly double the same week last year, J.P. Morgan analysts, led by Peter DeGroot, wrote. Next week will be a “record week for [alternative minimum tax] offerings,” the…
Stripe is positioning itself to play an even greater role in the artificial intelligence (AI) sector that already propelled its revenue to increase by a third to $6.8 billion last year, The Information reported Wednesday (July 22). The company processes payments for AI labs and developers, and it already takes a small cut of the surging sales…
While Freddie Mac’s weekly mortgage rate survey may show rates moving slightly lower this week, today’s rates are actually higher than they were at the same time last week (6.76% vs 6.69%). Financial news continued to focus on yesterday’s announcement of Treasury buybacks after Secretary Bessent spoke on CNBC this morning, but today’s bump in…
Claire O’Connor had a hard time believing her Pacific Palisades, CA, home carried any real wildfire risk—even after her insurance policy was dropped in November 2024. “I mean, as if our house is going to burn down,” the Los Angeles real estate agent recalled telling her husband at the time. “So many houses would have…
Andrew Van Sickle: Canada is always overshadowed by its larger neighbour, so your fund is rarely in the spotlight. Tell us a bit about it. Greg Eckel: It’s a general Canadian equity investment trust, North America’s second-oldest closed-end fund. It was set up in 1930, and listed in London in 1995. Think of it as…